跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,652 条关于
“Eleva Therapeutics”
全部
16,652
临床试验
3,590
药物
3,127
机构
1,127
资讯
8,808
去年
HLB Group to Resubmit Riboceranib for FDA Approval Following Second Rejection
去年
Eleva Partners with 3PBIOVIAN to Scale Production of Novel Complement Modulator for Rare Diseases
去年
Eleva Advances Factor H Therapy CPV-104 into First-in-Human Trial for Rare Kidney Disease C3 Glomerulopathy
11个月前
Eleva's CPV-104 Advances to Phase 1b Testing in C3G Patients After Successful Safety Evaluation
3天前
One04 Therapeutics Launches on Encouraging CPV-104 Phase 1 Interim Data in C3 Glomerulopathy
去年
Relay Therapeutics and Elevar Therapeutics Announce Licensing Agreement for Lirafugratinib
去年
Elevar Therapeutics Addresses Regulatory Trends and Rivoceranib/Camrelizumab Review
3年前
Elevar Therapeutics Seeks FDA Approval for Rivoceranib and Camrelizumab Combination in Unresectable Hepatocellular Carcinoma
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
第 1 页,共 881 页
上一页
下一页